American International Group, Inc. Biogen Inc. Transaction History

American International Group, Inc.

$8.86 Billion
Q2 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $539,166 - $680,786	-2,543 Reduced 4.89%	49,426 $10.7 Million
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $136,447 - $164,247	-613 Reduced 1.17%	51,969 $13.4 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $124,623 - $140,657	-492 Reduced 0.93%	52,582 $13.5 Million
Q2 2023 Aug 04, 2023	SELL	$275.25 - $318.06 $390,855 - $451,645	-1,420 Reduced 2.61%	53,074 $15.1 Million
Q1 2023 May 12, 2023	BUY	$256.56 - $292.34 $44,128 - $50,282	172 Added 0.32%	54,494 $15.2 Million
Q4 2022 Feb 10, 2023	BUY	$252.44 - $306.72 $1.49 Million - $1.81 Million	5,885 Added 12.15%	54,322 $15 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $257,574 - $355,172	-1,323 Reduced 2.66%	48,437 $12.9 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $1.19 Million - $1.42 Million	-6,351 Reduced 11.32%	49,760 $10.1 Million
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $343,554 - $432,860	-1,773 Reduced 3.06%	56,111 $11.8 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $309,233 - $397,410	-1,381 Reduced 2.33%	57,884 $13.9 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $1.63 Million - $2.13 Million	-5,775 Reduced 8.88%	59,265 $16.8 Million
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $633,773 - $1.01 Million	-2,447 Reduced 3.63%	65,040 $22.5 Million
Q1 2021 May 07, 2021	SELL	$242.95 - $284.63 $258,255 - $302,561	-1,063 Reduced 1.55%	67,487 $18.9 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $523,788 - $788,431	-2,217 Reduced 3.13%	68,550 $16.8 Million
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $1.02 Million - $1.17 Million	-3,834 Reduced 5.14%	70,767 $20.1 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $1.63 Million - $2.16 Million	-6,311 Reduced 7.8%	74,601 $20 Million
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $55,651 - $70,595	-207 Reduced 0.26%	80,912 $25.6 Million
Q4 2019 Feb 05, 2020	SELL	$220.06 - $304.07 $217,639 - $300,725	-989 Reduced 1.2%	81,119 $24.1 Million
Q3 2019 Nov 08, 2019	SELL	$217.44 - $243.88 $874,978 - $981,373	-4,024 Reduced 4.67%	82,108 $19.1 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $947,990 - $1.04 Million	-4,323 Reduced 4.78%	86,132 $20.1 Million
Q1 2019 May 06, 2019	SELL	$216.71 - $338.96 $974,328 - $1.52 Million	-4,496 Reduced 4.74%	90,455 $21.4 Million
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $399,926 - $506,549	-1,436 Reduced 1.49%	94,951 $28.6 Million
Q3 2018 Nov 09, 2018	BUY	$293.51 - $383.83 $205,750 - $269,064	701 Added 0.73%	96,387 $34.1 Million
Q2 2018 Aug 08, 2018	SELL	$257.52 - $306.91 $98,887 - $117,853	-384 Reduced 0.4%	95,686 $27.8 Million
Q1 2018 May 07, 2018	BUY	$260.13 - $367.91 $1.24 Million - $1.76 Million	4,782 Added 5.24%	96,070 $26.3 Million
Q4 2017 Feb 09, 2018	BUY	$307.64 - $344.58 $507,913 - $568,901	1,651 Added 1.84%	91,288 $29.1 Million
Q3 2017 Nov 09, 2017	BUY	$281.15 - $329.69 $25.2 Million - $29.6 Million	89,637	89,637 $28.1 Million

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

Vanguard Group Inc Valley Forge, PA

16.6M
Shares

$2.88 Billion
0.08% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.84 Billion
2.78% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.53 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.1M
Shares

$1.23 Billion
0.07% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

5.68M
Shares

$987 Million
0.83% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Account